UPDATE 2-Vertex rheumatoid arthritis drug meets study goals
* Vertex shares off 10 cents in broadly lower market (Adds study details, rival Pfizer drug, analyst comment, share price)
CORRECTED - UPDATE 3-Vertex rheumatoid arthritis drug meets study ...
NEW YORK, Sept 6 (Reuters) - Vertex Pharmaceuticals Inc (VRTX.O) said its experimental oral drug for rheumatoid arthritis met the main goals of a mid-stage .Read More
CORRECTED - UPDATE 3-Vertex rheumatoid arthritis drug meets study ...
* 66 pct hit ACR20 in 150 mg group vs 29 pct for placebo * 65 pct reach ACR20 with 100 mg of VX-509 * Vertex shares close up 2.2 pct at $45.57 (Adds .Read More
UPDATE 3-Vertex rheumatoid arthritis drug meets study goals ...
NEW YORK, Sept 6 (Reuters) - Vertex Pharmaceuticals Inc (VRTX.O) said its experimental oral drug for rheumatoid arthritis met the main goals of a mid-stage .Read More
Pluristem's PLX Cells Have Potential to Treat ARS. Vertex ...
Below is a look at some of the headlines for companies that made news in the healthcare sector on September 7, 2011. Pluristem Therapeutics Inc. (NASDAQ:PSTI .Read More
Exelixis says cancer drug meets main study goals, shares up 18%
{Proactive Investors via BioPortfolio} Drug maker Exelixis, Inc. (NASDAQ:EXEL) said that its experimental drug met its phase three endpoints of improving progre.Read More
Tofacitinib - Wikipedia, the free encyclopedia
Tofacitinib (formerly tasocitinib, CP-690550) is a drug being investigated by Pfizer for the treatment of rheumatoid arthritis (RA), psoriasis, inflammatory bowel .Read More
The Latest Rheumatoid Arthritis News - HealthCentral.com - Trusted ...
Keep up to date on all the latest Rheumatoid Arthritis research, drugs, and treatment.Read More
General principles of management of rheumatoid arthritis
The management of patients with rheumatoid arthritis (RA) is based upon an emerging understanding of the biology and natural history of the disease:An appreciation of .Read More
Pre-Clinical Rheumatoid Arthritis: Identification, Evaluation and ...
Rheumatoid arthritis (RA) likely develops in several phases, beginning with genetic risk, followed by asymptomatic autoimmunity, then finally, clinically-apparent .Read More
Arthritis News and Video - FOX News Topics - FOXNews.com
Pfizer Says Arthritis Drug Comparable To Humira In Study; Bristol-Myers: FDA Expands Approval Of Rheumatoid Arthritis Drug; Sanofi, Regeneron Antibody .Read More
Hep C Trial Shows Best Chance for Non-Responders | Hepatitis ...
Hepatitis Central The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments.Read More
Juvenile Idiopathic Arthritis
Juvenile rheumatoid arthritis (JRA) is the most common chronic rheumatologic disease in children and is one of the most common chronic diseases of childhood.Read More
Minocin/Minocycline Studies | Arthritis Information
Archives of Arthritis Insight Forums and message boards from user posts.Read More
Pharmacokinetics and pharmacodynamics of low-dose methotrexate in ...
Jaroslav Chládek, 1 Jiøı´ Grim, 1 Jiøina Martínková, 1 Marie Šimková, 2 Jaroslava Vanı`èková, 2 Vìra Koudelková, 2 and Marie Noièková 2.Read More
US Food and Drug Administration: c00001 - Scribd
6 Royal Nationa. Hospital for .Rheumatic Diseases NHS Trust ACEFAI w- > v;* -*y c’: .J; .I>. de1 (dtig;) i ‘) 3 012$&4,3~q2 F” FJ 1 i: i-L i _’ ML.~ Fax .Read More
